For the quarter ended December 2022, CBOE Global (CBOE) reported revenue of $457.1 million, up 17.1% over the same period last year. EPS came in at $1.80, compared to $1.70 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $460.17 million, representing a surprise of -0.67%. The company delivered an EPS surprise of +1.69%, with the consensus EPS estimate being $1.77.
While investors closely watch year-over-year changes in headline numbers — revenue and earnings — and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company’s underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock’s price performance more accurately.
Here is how CBOE performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Average Daily Volume by Product -Options- Index options: 3359 thousand versus 2973.25 thousand estimated by five analysts on average.
- Average Daily Volume by Product – Futures: 193 thousand versus 198.31 thousand estimated by five analysts on average.
- Average Revenue Per Contract by Product -Options- Multiple-Listed Options: $0.06 versus $0.06 estimated by four analysts on average.
- Average Daily Notional Volume by Product – Global FX: 40.8 billion versus the four-analyst average estimate of 39.4 billion.
- Average Revenue Per Contract by Product -Options- Index options: $0.88 compared to the $0.89 average estimate based on four analysts.
- Average Revenue Per Contract by Product – Futures: $1.69 versus the four-analyst average estimate of $1.72.
- Average Revenue Per Contract by Product – U.S. equities – Exchange- Net captures: $0.02 compared to the $0.02 average estimate based on three analysts.
- Revenues – Access and capacity fees: $82.70 million compared to the $83.36 million average estimate based on seven analysts. The reported number represents a change of +11.2% year over year.
- Revenues – Market data fees: $71.70 million versus $71.86 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +12.9% change.
- Revenues – Other revenue: $11.50 million compared to the $11.23 million average estimate based on five analysts. The reported number represents a change of -20.1% year over year.
- Revenues – Regulatory fees: $120.40 million compared to the $77.03 million average estimate based on four analysts. The reported number represents a change of +241.1% year over year.
- Revenues – Transaction and clearing fees: $718.40 million versus $630.86 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +5.8% change.
View all Key Company Metrics for CBOE here>>>
Shares of CBOE have returned -2.4% over the past month versus the Zacks S&P 500 composite’s +9% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Cboe Global Markets, Inc. (CBOE) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Image and article originally from www.nasdaq.com. Read the original article here.